SHISEIDO Future LX Day/Jour

Dosage form: cream
Ingredients: Ensulizole 1.02g in 51g, Octinoxate 2.5g in 51g, Octocrylene 2.55g in 51g
Labeler: SHISEIDO AMERICA INC.
NDC Code: 52686-221

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Shiseido Future Solution

Drug Facts

Active ingredientPurpose
ENSULIZOLE 2%Sunscreen
OCTINOXATE 4.9%Sunscreen
OCTOCRYLENE 5%Sunscreen

Uses
  • helps prevent sunburn
  • higher SPF gives more sunburn protection

Warnings

For external use only

When using this product
  • keep out of eyes. Rinse with water to remove

Stop use and ask a doctor if
  • rash or irritation develops and lasts.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison'Control Center right away.

Directions
  • apply smoothly to face before sun exposure and as needed.
  • children under 6 months of age: ask a doctor.

Inactive ingredients

WATER, CYCLOMETHICONE, GLYCERIN, DIPROPYLENE GLYCOL, BEHENYL ALCOHOL, SD ALCOHOL 40-B, DIPHENYLSILOXY PHENYL TRIMETHICONE, SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL, POLYSORBATE 60, DIMETHICONE, GLYCERYL STEARATE, TRIETHANOLAMINE, PEG-20, ERYTHRITOL, PIPERIDINEPROPIONIC ACID, XANTHAN GUM, SACCHAROMYCES FERMENT LYSATE FILTRATE, GLYCINE, ARGININE HCl, MAGNESIUM ASCORBYL PHOSPHATE, SODIUM ACETYLATED HYALURONATE, ONONIS SPINOSA ROOT EXTRACT, AVERRHOA CARAMBOLA LEAF EXTRACT, HIBISCUS ESCULENTUS FRUIT EXTRACT, CAMELLIA SINENSIS LEAF EXTRACT, SODIUM METHYL STEAROYL TAURATE, BUTYLENE GLYCOL, SODIUM CITRATE, SODIUM METAPHOSPHATE, CITRIC ACID, ALCOHOL, BHT, TOCOPHEROL, PHENOXYETHANOL, FRAGRANCE, IRON OXIDES

Questions ?

1-800-906-7503

PRINCIPAL DISPLAY PANEL - 51g Jar Carton

SHISEIDO

Future Solution LX

Daytime Protective Cream

SPF 15•PA+

SUNSCREEN

SHISEIDO FUTURE  LX DAY/JOUR
ensulizole, octinoxate and octocrylene cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:52686-221
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Ensulizole (Ensulizole) Ensulizole1.02 g  in 51 g
Octinoxate (Octinoxate) Octinoxate2.5 g  in 51 g
Octocrylene (Octocrylene) Octocrylene2.55 g  in 51 g
Packaging
#Item CodePackage Description
1NDC:52686-221-501 JAR (JAR) in 1 BOX
151 g in 1 JAR
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35209/01/2009
Labeler - SHISEIDO AMERICA INC. (782677132)
Establishment
NameAddressID/FEIOperations
SHISEIDO AMERICA INC.782677132ANALYSIS, MANUFACTURE

Revised: 12/2009
 
SHISEIDO AMERICA INC.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web4)